Skip to main content

Table 3 Co-pathogen infection of patients with M. pneumoniae

From: Mycoplasma pneumoniae infection outbreak in Guangzhou, China after COVID-19 pandemic

Respiratory pathogens

2020 ∼ 2022

(n = 95)

2023

(n = 754)

P value

non-SMPP

(n = 639)

SMPP

(n = 201)

P value

Virus

7(7.4%)

119(15.8%)

0.030

84(13.2%)

42(20.9%)

0.007

Infuenza virus A

0

14(1.9%)

0.362

14(2.2%)

2(1.0%)

0.432

Infuenza virus B

0

10(1.3%)

0.532

7(1.1%)

3(1.5%)

0.936

Respiratory syncytial virus

1(1.1%)

22(2.9%)

0.472

14(2.2%)

9(4.5%)

0.083

Adenovirus

1(1.1%)

20(2.7%)

0.551

16(2.5%)

5(2.5%)

0.99

Rhinovirus

1(1.1%)

34(4.5%)

0.186

20(3.1%)

14(7.0%)

0.016

Parainfuenza virus

1(1.1%)

15(2.0%)

0.816

15(2.3%)

1(0.5%)

0.168

Metapneumovirus

0

4(0.5%)

1

4(0.6%)

0

0.578

cytomegalovirus

1(1.1%)

4(0.5%)

0.448

2(0.3%)

3(1.5%)

0.171

Epstein-Barr virus

0

3(0.4%)

1

1(0.2%)

2(1.0%)

0.144

Herpesvirus hominis

0

2(0.3%)

1

0

2(1.0%)

0.057

Human bocavirus

1(1.1%)

6(0.8%)

0.566

6(0.9%)

1(0.5%)

0.876

Enterovirus

0

1(0.1%)

1

0

2(1.0%)

0.057

Coronavirus

1(1.1%)

2(0.3%)

0.300

1(0.2%)

2(1.0%)

0.144

Bacteria

9(9.5%)

82(10.9%)

0.677

61(9.5%)

30(14.9%)

0.032

Streptococcus pneumoniae

4(4.2%)

41(5.4%)

0.615

27(4.2%)

18(9.0%)

0.009

Haemophilus influenzae

2(2.1%)

26(3.4%)

0.700

22(3.4%)

6(3.0%)

0.752

Klebsiella pneumoniae

0

1(0.1%)

0.034

1(0.2%)

0

1

Staphylococcus aureus

0

19(2.5%)

0.231

13(2.0%)

6(3.0%)

0.604

Pseudomonas aeruginosa

1(1.1%)

1(0.1%)

0.211

1(0.2%)

1(0.5%)

1

Moraxella catarrhalis

0

5(0.7%)

1

3(0.5%)

2(1.0%)

0.750

Bordetella pertussis

0

4(0.5%)

1

3(0.5%)

1(0.5%)

1

Legionella pneumophila

0

4(0.5%)

1

2(0.3%)

2(1.0%)

0.243

Stenotrophomonas maltophilia

0

2(0.3%)

1

1(0.2%)

1(0.5%)

0.422

Enterococcus faecium

1(1.1%)

0

0.112

1(0.2%)

0

1

Staphylococcus equorum

1(1.1%)

0

0.112

1(0.2%)

0

1

Fungus

0

1(0.1%)

1

1(0.2%)

0

1

Chlamydia

0

5(0.7%)

1

4(0.6%)

1(0.5%)

1